Does Nebraska Medicaid cover GLP-1s for weight loss?

Nebraska Medicaid covers Wegovy and Zepbound for heart risk, MASH or sleep apnea, not for weight loss alone

Not for weight loss alone
By Iacob Pastina, Independent Researcher & Publisher
Updated · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

If you are an adult and weight loss is your only reason, Nebraska Medicaid does not cover a GLP-1.

If one of the uses below applies to you, your prescriber can ask Nebraska Medicaid to cover that drug. Read the rule and its criteria.

  • Nofor adult weight loss alone
  • Oct 1, 2026when the program last revised the rules we checked
  • $99/molowest cash price in Nebraska, at HealthRX

Which drugs Nebraska Medicaid covers, and for what:

Wegovy
Heart risk, as injection or tablets, or MASH, as the injection
Zepbound
Sleep apnea

We checked 4 official documents on October 15, 2026. This is information, not medical advice or a benefit decision.

What does a GLP-1 cost without insurance in Nebraska?

7 programs that serve Nebraska publish a complete monthly price, from $99 at HealthRX to $299 at Willow.

Programs that serve Nebraska, lowest monthly price first

Some programs are affiliate partners, and we may earn a commission if you join through our link. Payment never moves a row. How we rank

3 more programs serve Nebraska without one complete monthly price: Collective, Maximus and Wellorithm. Compare their terms in the price index.

We left out 30 programs whose service-area list has a caveat for Nebraska or is incomplete, so confirm your address at intake.

A program that serves Nebraska still decides whether to prescribe. Before enrolling, confirm whether it accepts your Medicaid plan and whether your prescribed treatment is covered. The advertised cash prices are not insurance copays. Most listed programs sell compounded semaglutide or tirzepatide, which is not FDA-approved. Check a compounded provider before you pay.

  • Lowest in Nebraska$99/moAt HealthRX, the lowest complete monthly price among programs that serve Nebraska.
  • National median$124/moThe median advertised recurring price across 10 compounded programs we track, a national benchmark, not a measured Nebraska average.
  • National range$49 to $299The lowest and highest advertised recurring prices in that group.

What does Nebraska Medicaid cover for GLP-1s?

Here is our summary of the Nebraska Medicaid rules we checked, with their criteria and limits.

Nebraska Medicaid covers Wegovy for heart risk or MASH and Zepbound for sleep apnea, not GLP-1 medicines for weight loss alone, under its state plan drug limits and its current Wegovy and Zepbound prior authorization forms. Nebraska Medicaid can approve Wegovy injection or tablets to lower your heart risk if you are 45 to 74 with a past heart attack, stroke or peripheral artery disease and a BMI of 30, or 27 with a weight-related condition. It can also approve Wegovy injection if you have MASH with F2 or F3 liver fibrosis. It covers Zepbound only if you are an adult with moderate to severe obstructive sleep apnea and a BMI of 30 or more, and breathing devices did not work for you or you could not use them. The forms ask for at least 6 months in a medically supervised weight program, and heart-risk renewals ask you to keep off 5% weight loss. Heritage Health plans run most pharmacy benefits, so ask your plan for its approved criteria.

A drug on the preferred list is not covered for every use, so check the rule for yours. A weight-loss exclusion leaves diabetes and other medical requests to their own rules.

We checked Nebraska Medicaid PA form: Wegovy, last reviewed January 2026 on October 15, 2026.

We checked Nebraska Medicaid PA form: Zepbound, sleep apnea only, last revised July 1, 2025 on October 15, 2026.

We checked Nebraska Medicaid preferred drug list with PA criteria, updated October 1, 2026 on October 15, 2026.

We checked Nebraska Medicaid state plan, prescribed drug limitations (weight-loss agents excluded) on October 15, 2026.

What should you ask Nebraska Medicaid before you pay?

Call your Medicaid plan, Medicare drug plan or private insurer with these questions, and keep the reference number for each call.

Before you pay cash, confirm:

  • Whether your plan covers your exact drug, form and dose for your diagnosis and age.
  • Whether you are in fee-for-service or a managed-care plan, and who handles your prior authorization.
  • Which records your prescriber must send with the request.
  • Which pharmacy can fill it, and your drug copay apart from any visit, lab or membership fees.
  • Whether paying cash affects your benefits.
  • If the plan says no, the reason in writing, how to ask for a review and the deadline on the notice.

An “insurance accepted” badge does not tell you your benefit, so ask your plan how its review works.

What paperwork does prior authorization need?

Your prescriber sends Nebraska Medicaid a request with the records that show you meet the rule for your drug and diagnosis, and Nebraska Medicaid decides.

What Nebraska Medicaid's own criteria ask for, from the documents we read:

  • At least 6 months in a medically supervised weight program.
  • For heart-risk renewals, records showing you kept off 5% weight loss.

What your prescriber usually sends:

  • The condition the request relies on, as Nebraska Medicaid names it: Wegovy for heart risk, as injection or tablets, or MASH, as the injection; Zepbound for sleep apnea.
  • Your BMI, with the height and weight it comes from and the date your prescriber measured them.
  • Chart notes that document the condition, such as a sleep study for sleep apnea or the liver scarring stage for MASH, where the rule asks for them.
  • The exact drug, form and dose your prescriber requests, and whether you have diabetes, because some routes exclude it.
  • What you have tried already: diet and activity changes, and any earlier medicine the rule asks about.
  • For a renewal, your weight, refill and treatment records since the first approval.

Your prescriber works from these Nebraska Medicaid documents:

Your prescriber's office files the request; you cannot file it yourself. If Nebraska Medicaid says no, ask for the reason in writing, because the notice tells you how to ask for a review and by when.

How does Medicare cover GLP-1s in Nebraska?

Medicare's GLP-1 Bridge follows federal rules in every state, so Nebraska Medicaid's policy does not decide your Medicare benefit.

GLP-1 Bridge
If your weight-management prescription qualifies and Humana, CMS's central processor, approves it, your drug copay is $50 a month. That copay does not count toward your Part D out-of-pocket spending.
Regular Part D
Ask your drug plan whether it covers your exact medicine for your diagnosis. A plan denial does not by itself make you eligible for the Bridge. Our Medicare GLP-1 coverage guide goes drug by drug.

We checked CMS's Bridge guidance for Part D plans on September 26, 2026.

Who can help with coverage in Nebraska?

Two free official services can help you, and we earn no commission from either.

Medicaid
If a managed-care plan runs your drug benefit, call the member-services number on your card for its criteria and a written decision. Nebraska Department of Health and Human Services
Medicare counseling
Your State Health Insurance Assistance Program (SHIP) explains a plan or notice for free. It does not approve a prescription. Nebraska SHIP counseling

Questions about GLP-1 access in Nebraska

Does Nebraska Medicaid cover GLP-1 medication for weight loss?

Nebraska Medicaid covers Wegovy for heart risk or MASH and Zepbound for sleep apnea, not GLP-1 medicines for weight loss alone, under its state plan drug limits and its current Wegovy and Zepbound prior authorization forms.

Nebraska Medicaid can approve Wegovy injection or tablets to lower your heart risk if you are 45 to 74 with a past heart attack, stroke or peripheral artery disease and a BMI of 30, or 27 with a weight-related condition. It can also approve Wegovy injection if you have MASH with F2 or F3 liver fibrosis. It covers Zepbound only if you are an adult with moderate to severe obstructive sleep apnea and a BMI of 30 or more, and breathing devices did not work for you or you could not use them. The forms ask for at least 6 months in a medically supervised weight program, and heart-risk renewals ask you to keep off 5% weight loss. Heritage Health plans run most pharmacy benefits, so ask your plan for its approved criteria. Before you pay, confirm your exact drug, your diagnosis, any age rules and your plan's authorization steps.

Is Medicare GLP-1 coverage different in Nebraska?

Yes.

Medicare's GLP-1 Bridge follows federal eligibility rules in every state, not Nebraska Medicaid's policy. Your ordinary Part D coverage depends on your prescription and your drug plan, and the Bridge runs its own eligibility and authorization review.

Can I get GLP-1 medication delivered in Nebraska?

Yes, from 10 online programs that publish a service area including Nebraska.

At intake, confirm your address, the exact medication and any pharmacy limits, because a state listing does not guarantee you a prescription or a delivery date.

How much does GLP-1 treatment cost in Nebraska?

Among programs that serve Nebraska, the lowest complete monthly price we found is $99 at HealthRX.

Across the 10 compounded programs we track nationally, the median advertised recurring price is $124/mo, from $49 to $299. That national figure is not a measured Nebraska average, insurance copay or quote for your dose.

Featured Partners

Affiliate partners we feature. We may earn a commission.

Embody

Embody illustration of a compounded semaglutide injection vial
from $49/mo·Compounded

Collective

Collective provider illustration of compounded semaglutide injection vial
from $59/mo + $199/year membership after 21 days·Compounded

Gala

Current program options·Brand & Compounded

Check the medication, commitment and total price for your selected plan.

Affiliate links, we earn a commission at no extra cost to you. These are featured partners, prioritized by our affiliate economics, not an editorial "best" ranking. Published scores have different evidence limits and do not establish better care. See the program comparison and scoring limitations.